←Back to Expert Scholars
Translational Medicine / 转化医学Neoadjuvant Therapy, Pancreatic Cancer
Matthew Katz
MD
🏢MD Anderson Cancer Center🌐USA
Professor and Chair, Department of Surgical Oncology
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Matthew Katz is chair of surgical oncology at MD Anderson and co-led Alliance A021501 evaluating neoadjuvant mFOLFIRINOX with or without stereotactic body radiation in borderline resectable pancreatic cancer. He is a leader in surgical management including vascular reconstruction after neoadjuvant therapy.
Share:
🧪Research Fields 研究领域
pancreatic surgical oncology
borderline resectable pancreas
neoadjuvant chemoradiation
vascular resection
Alliance A021501
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Matthew Katz 的研究动态
Follow Matthew Katz's research updates
留下邮箱，当我们发布与 Matthew Katz（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment